Androgen receptor signaling inhibitor (ARSI): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
4
Conditions studied
7
US states with sites
4
Countries
Phase breakdown
Phase 1 1
Phase 2 1
Conditions being studied
| Condition | Trials |
|---|---|
| Prostate Cancer | 2 |
| Hormone-refractory Prostate Cancer | 1 |
| Malignant Neoplasm of Prostate | 1 |
| Secondary Malignant Neoplasm of Prostate | 1 |
Recruiting trials involving Androgen receptor signaling inhibitor (ARSI)
- MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
- Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Common questions
How many recruiting trials involve Androgen receptor signaling inhibitor (ARSI)?
2 recruiting trials across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.